Corporate Banner
Satellite Banner
Crystallography
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

SARomics Biostructures and Xbrane Bioscience Form a Strategic Partnership

Published: Thursday, January 30, 2014
Last Updated: Wednesday, January 29, 2014
Bookmark and Share
Strategic partnership to deliver “off-the-shelf” protein structure services.

SARomics Biostructures and Xbrane Bioscience have signed a strategic partnership for “off-the-shelf” protein structures. The two companies will combine their world leading expertise within their respective fields to deliver “off-the-shelf” protein structure services.

The “off-the-shelf” concept is a service product that simplifies and de-risks drug discovery activities. It is targeted towards structure-based design projects where protein structure information is used to accelerate the drug discovery process.

In an “off-the shelf” product, crystals suitable for X-ray crystallographic studies of the protein in question have already been obtained. In a service project the protein can thus, within a very short turn-around time, be co-crystallized with a customers' compounds, revealing the mode of interaction of the compound with the protein target without the necessity for the customer to build up the same expertise in-house.

In this partnership the advanced structural biology platform and expertise contributed by SARomics Biostructures will be used to produce, crystallize and determine the structure of a number of challenging proteins belonging to the epigenetic pathway.

Targeting proteins involved in epigenetic mechanisms (the cellular processes associated with the modification of chromatin) has emerged as an important new therapeutic opportunity for treating cancer, diabetes, inflammatory diseases and more.

Xbrane Bioscience will provide its world leading know-how and proprietary technology within protein expression in order to produce the selected “off-the-shelf” proteins.

Björn Walse, CEO of SARomics Biostructures, said “We are excited about the opportunity to work with Xbrane Bioscience on this frontline project that clearly leverages the competitiveness of both companies”.

“The agreement with SARomics is an important step for our growth strategy and gives us an opportunity to demonstrate our capabilities within optimization of protein production in E. coli”, says Siavash Bashiri, CEO at Xbrane Bioscience.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

A New EU-Funded Industry-Academia Drug Discovery Partnership Targets Challenging Kinases
Industry and academia join to create the Translational Kinase Tumor Inhibitor Discovery Consortium.
Wednesday, April 10, 2013
SARomics Biostructures and Red Glead Discovery Enters into Drug Discovery Collaboration
The companies will perform a joint collaborative project with the goal of developing novel lead compounds against epigenetic pathway targets.
Thursday, October 25, 2012
SARomics Biostructures Brings in New Strategic Owners
Innovationsbron AB and LUIS AB are investing in and becoming new co-owners of the company.
Saturday, September 15, 2012
Scientific News
Crouching Protein, Hidden Enzyme
A new study led by scientists at The Scripps Research Institute (TSRI) and the University of California (UC), Berkeley shows how a crucial molecular enzyme starts in a tucked-in somersault position and flips out when it encounters the right target.
3D Images of Enzymes May Lead to Improved Antibiotics
Research advances understanding of how crucial proteins function.
Supply Chain
Chemists discover how a single enzyme maintains a cell’s pool of DNA building blocks.
Seeing DROSHA for the First Time
IBS team gets the first glimpse of elusive protein structure.
Scientists Blueprint Tiny Cellular ‘Nanomachine’
Scientists have drawn up molecular blueprints of a tiny cellular ‘nanomachine’, whose evolution is an extraordinary feat of nature, by using one of the brightest X-ray sources on Earth.
Pioneering Brain Cancer Technique Could Lead to Better Prognosis for Patients
4,000th paper published from Diamond research could improve outcomes for brain cancer sufferers.
Big Moves in Protein Structure Prediction and Design
Custom design with atomic level accuracy enables researchers to craft a whole new world of proteins.
Pushing Drug Discovery Forward
A new study, led by scientists at The Scripps Research Institute (TSRI), shows how different pharmaceutical drugs hit either the “on” or “off” switch of a signaling protein linked to asthma, obesity and type 2 diabetes.
Solved Structure of S. pneumoniae Enzyme Could Lead to New Antibiotics
Scientists solve structure of a key bacterial enzyme from streptococcus pneumoniae: a major cause of bacterial meningitis, bronchitis, ear infection and pneumonia.
A New Way to Look at MOFs
International study challenges prevailing view on how metal organic frameworks store gases.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!